A Multiagent System for Integrated Detection of Pharmacovigilance Signals

Pharmacovigilance is the scientific discipline that copes with the continuous assessment of the safety profile of marketed drugs. This assessment relies on diverse data sources, which are routinely analysed to identify the so-called “signals”, i.e. potential associations between drugs and adverse effects, that are unknown or incompletely documented. Various computational methods have been proposed to support domain experts in signal detection. However, recent comparative studies illustrated that current methods exhibit high false-positive rates, significantly variable performance across different datasets used for analysis and events of interest, but also complementarity in their outcomes. In this regard, in order to reinforce accurate and timely signal detection, we elaborated through an agent-based approach towards systematic, joint exploitation of multiple heterogeneous signal detection methods, data sources and other drug-related resources under a common, integrated framework. The approach relies on a multiagent system operating based on a collaborative agent interaction protocol, aiming to implement a comprehensive workflow that comprises of method selection and execution, as well as outcomes’ aggregation, filtering, ranking and annotation. This paper presents the design of the proposed multiagent system, discusses implementation issues and demonstrates the applicability of the proposed solution in an example signal detection scenario. This work constitutes a step towards large-scale, integrated and knowledge-intensive computational signal detection.

[1]  Vassilis Koutkias,et al.  A multiagent system enhancing home-care health services for chronic disease management , 2005, IEEE Transactions on Information Technology in Biomedicine.

[2]  Boris Motik,et al.  OWL 2 Web Ontology Language: structural specification and functional-style syntax , 2008 .

[3]  Sabine Van Huffel,et al.  HealthAgents: distributed multi-agent brain tumor diagnosis and prognosis , 2009, Applied Intelligence.

[4]  David Madigan,et al.  Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.

[5]  R. Richesson,et al.  Clinical research informatics , 2012 .

[6]  N. Shah,et al.  Pharmacovigilance Using Clinical Notes , 2013, Clinical pharmacology and therapeutics.

[7]  Marie Lindquist,et al.  The Need for Definitions in Pharmacovigilance , 2007, Drug safety.

[8]  M. Harrison‐Woolrych Evaluating medicines: let's use all the evidence , 2007, The Medical journal of Australia.

[9]  Lotfi Bouzguenda,et al.  Designing an Architectural Style for Dynamic Medical Cross-Organizational Workflow Management System: An Approach Based on Agents and Web Services , 2014, Journal of Medical Systems.

[10]  John Yen,et al.  A distributed adverse drug reaction detection system using intelligent agents with a fuzzy recognition‐primed decision model , 2007, Int. J. Intell. Syst..

[11]  Yu-Chuan Li,et al.  Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers , 2015, MedInfo.

[12]  G Niklas Norén,et al.  Modern methods of pharmacovigilance: detecting adverse effects of drugs. , 2009, Clinical medicine.

[13]  Hua Xu,et al.  Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs , 2012, J. Am. Medical Informatics Assoc..

[14]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[15]  Matthias Klusch,et al.  Brokering and Matchmaking for Coordination of Agent Societies: A Survey , 2001, Coordination of Internet Agents: Models, Technologies, and Applications.

[16]  Yu Tian,et al.  Use of an Agent-Based Simulation Model to Evaluate a Mobile-Based System for Supporting Emergency Evacuation Decision Making , 2014, Journal of Medical Systems.

[17]  J. Oliveira,et al.  The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools , 2013, Pharmacoepidemiology and drug safety.

[18]  Haibo He,et al.  A Boost Voting Strategy for Knowledge Integration and Decision Making , 2008, ISNN.

[19]  Eugene Santos,et al.  Fusing multiple Bayesian knowledge sources , 2011, Int. J. Approx. Reason..

[20]  M. Lindquist Use of Triage Strategies in the WHO Signal-Detection Process , 2007, Drug safety.

[21]  Yen S. Low,et al.  Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art , 2014, Drug Safety.

[22]  M. Schuemie,et al.  Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey , 2013, Drug Safety.

[23]  Pavel,et al.  Multi-agent Systems and Cloud Computing for Controlling and Managing Chemical and Food Processes , 2012 .

[24]  Graciela Gonzalez-Hernandez,et al.  Utilizing social media data for pharmacovigilance: A review , 2015, J. Biomed. Informatics.

[25]  Régis Beuscart,et al.  Data Mining to Generate Adverse Drug Events Detection Rules , 2011, IEEE Transactions on Information Technology in Biomedicine.

[26]  N. Shah,et al.  Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.

[27]  A Bate,et al.  Decision support methods for the detection of adverse events in post-marketing data. , 2009, Drug discovery today.

[28]  David Sánchez,et al.  Agents applied in health care: A review , 2010, Int. J. Medical Informatics.

[29]  Nicolas Lhuillier,et al.  FOUNDATION FOR INTELLIGENT PHYSICAL AGENTS , 2003 .

[30]  Martijn J. Schuemie,et al.  Using Electronic Health Care Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods , 2012, Medical care.

[31]  GonzalezGraciela,et al.  Utilizing social media data for pharmacovigilance , 2015 .

[32]  Marie-Christine Jaulent,et al.  Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks , 2015, Drug Safety.

[33]  Javier Vázquez-Salceda,et al.  UCTx: A Multi-Agent System to Assist a Transplant Coordination Unit , 2004, Applied Intelligence.

[34]  Taha A. Kass-Hout,et al.  Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter , 2014, Drug Safety.

[35]  P Ryan,et al.  Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.

[36]  Hua Xu,et al.  Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records , 2013, J. Am. Medical Informatics Assoc..

[37]  Cynna Selvy,et al.  Unified Medical Language System (UMLS) , 2015 .

[38]  Z. Bankowski,et al.  Council for International Organizations of Medical Sciences , 1991 .

[39]  Quynh-Nhu Numi Tran,et al.  MOBMAS: A methodology for ontology-based multi-agent systems development , 2008, Inf. Softw. Technol..

[40]  Jennifer Chu-Carroll,et al.  Building Watson: An Overview of the DeepQA Project , 2010, AI Mag..

[41]  Michael Luck,et al.  A Manifesto for Agent Technology: Towards Next Generation Computing , 2004, Autonomous Agents and Multi-Agent Systems.

[42]  正博 頭金 FDA adverse event reporting system (FAERS) , 2015 .

[43]  A. Pariente,et al.  Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? , 2009, Pharmacoepidemiology and drug safety.

[44]  David Madigan,et al.  Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.

[45]  Anya Okhmatovskaia,et al.  An Ontology-Driven Framework for Deploying JADE Agent Systems , 2008, 2008 IEEE/WIC/ACM International Conference on Web Intelligence and Intelligent Agent Technology.

[46]  Carol Friedman,et al.  Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions , 2013, J. Am. Medical Informatics Assoc..

[47]  Uwe Aickelin,et al.  Comparison of algorithms that detect drug side effects using electronic healthcare databases , 2013, Soft Comput..

[48]  Vincent Bauchau,et al.  Signal detection on spontaneous reports of adverse events following immunisation: a comparison of the performance of a disproportionality-based algorithm and a time-to-onset-based algorithm , 2014, Pharmacoepidemiology and drug safety.

[49]  G. Niklas Norén,et al.  A Decade of Data Mining and Still Counting , 2010, Drug safety.

[50]  Vassilis Koutkias,et al.  Leveraging Post-marketing Drug Safety Research through Semantic Technologies: The PharmacoVigilance Signal Detectors Ontology , 2014, SWAT4LS.

[51]  Vassilis Koutkias,et al.  Engineering agent-mediated integration of bioinformatics analysis tools , 2007, Multiagent Grid Syst..

[52]  Matjaz Gams,et al.  A Multi-Agent Care System to Support Independent Living , 2014, Int. J. Artif. Intell. Tools.

[53]  Abdul Mateen Rajput,et al.  Automatic detection of adverse events to predict drug label changes using text and data mining techniques , 2013, Pharmacoepidemiology and drug safety.

[54]  G. Niklas Norén,et al.  Temporal pattern discovery in longitudinal electronic patient records , 2010, Data Mining and Knowledge Discovery.

[55]  Edmund H. Durfee,et al.  Distributed Problem Solving and Planning , 2001, EASSS.

[56]  Juan Ruiz,et al.  Monitoring Gestational Diabetes Mellitus with Cognitive Agents and Agent Environments , 2011, 2011 IEEE/WIC/ACM International Conferences on Web Intelligence and Intelligent Agent Technology.

[57]  Hua Xu,et al.  Identifying Plausible Adverse Drug Reactions Using Knowledge Extracted from the Literature , 2014, AMIA.

[58]  David Madigan,et al.  Empirical Performance of LGPS and LEOPARD: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.